RecruitingNCT06894498

Five PLus Year EffIcacy of Endoscopic Sleeve Gastroplasty (ESG) for Sustained WeigHT Loss


Sponsor

Boston Scientific Corporation

Enrollment

100 participants

Start Date

Mar 31, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

The objective of this study is to assess the long term weight loss and weight loss journey of patients who received an Endoscopic Sleeve Gastroplasty (ESG) 5 or more years prior to enrollment.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying No Intervention: Observational Cohort for people with obesity and obesity-related medical conditions and weight loss. The study is currently recruiting participants at 8 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNo Intervention: Observational Cohort

No Intervention, Observational Cohort


Locations(8)

Endeavor Health Evanston Hospital

Evanston, Illinois, United States

The University of Texas Health Science Center at Houston

Bellaire, Texas, United States

The BMI Clinic

Double Bay, New South Wales, Australia

CHU de Strasbourg, IHU-Strasbourg

Strasbourg, France

Mohak hi-tech Specialty Hospital

Indore, Madhya Pradesh, India

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Rome, Italy

New You Medical Center

Riyadh, Saudi Arabia

Spire Southampton

Southampton, Hampshire, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06894498


Related Trials